SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1477Prior to the "not approvable" letter, there was no time line for any FIan@SI-11/9/2007
1476>>It appears the fda *may* have just agreed mnta's characterization isIRWIN JAMES FRANKEL-11/9/2007
1475Its a brutal market right now. Once the threat of lovenox approval went away, I rkrw-11/9/2007
147410Q filed: sec.govDewDiligence_on_SI-11/8/2007
1473Graphic on M118 MoA: siliconinvestor.com Probably old hat to posters here, butDewDiligence_on_SI-11/8/2007
1472EV now about $60M. Being priced like it is going bankrupt. ijIRWIN JAMES FRANKEL-11/8/2007
1471>>Worst case could be they do whatever the fda has asked, refile in a yeartuck-11/7/2007
1470IJ, I don't know, but I'd speculate that it probably has something to dIan@SI-11/7/2007
1469<i>Worst case could be they do whatever the fda has asked, refile in a yeaSteve Lokness-11/7/2007
1468Ram's lucky number?rkrw-11/7/2007
1467Unusual AH and pre-market trades AH yesterday there were probably 30 trades allIRWIN JAMES FRANKEL-11/7/2007
1466Worst case could be they do whatever the fda has asked, refile in a year or two,rkrw-11/7/2007
1465[Semi on-topic] Bayer plans 50-000-patient study of the anticoagulant RivaroxabaDewDiligence_on_SI-11/6/2007
1464<i>>Near worst case is probably a Phase I safety study - that would likDewDiligence_on_SI-11/6/2007
1463Just for the record, and certainly not because it should make any difference fortom pope-11/6/2007
1462Sanofi - that would make sense. Thanks.LJM-11/6/2007
1461I suspect it was that last Citizen's Petition filed by Sanofi that raised thBiomaven-11/6/2007
1460I hope SANDOZ does sue, if the next meeting with the FDA is as "fuzzy"LJM-11/6/2007
1459Sorry, I'm Euro challenged. ;-)Ian@SI-11/6/2007
1458Please see msg #1428 for the latest Lovenox sales figures.DewDiligence_on_SI-11/6/2007
1457On WPI’s 3Q07 CC early this morning, WPI said they had not yet heard from AmphasDewDiligence_on_SI-11/6/2007
1456Not much new here. Last line indicates that Lovenox mkt is approaching $4B/yr -Ian@SI-11/6/2007
1455Thank - I figured as much. For TEVA this is a rounding error. WPI will get askIRWIN JAMES FRANKEL-11/6/2007
1454<i>Anyone think that TEVA and WPI got the same "not approvable" DewDiligence_on_SI-11/6/2007
1453Anyone think that TEVA and WPI got the same "not approvable" letter? IRWIN JAMES FRANKEL-11/6/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News